Daniel Elger Insider Profile
4 Followers
Daniel Elger, former Chief Financial Officer at E Therapeutics, holds 30.00K shares in E Therapeutics (Ticker: GB:ETX). Most recently, Daniel Elger Bought 15,000 shares of E Therapeutics on Feb 15, 2013 for an estimated value of 4.80K .
Daniel Elger's Trading History
| ETXE Therapeutics | Feb 15, 2013 | ― | Informative Buy | 4.80K | £2.70K | ||||||||||||||||||||||
GB:ETX
| |||||||||||||||||||||||||||
You May Also Like
Daniel Elger insider profile FAQ
What is the percentage of profitable transactions made by Daniel Elger?
The percentage of profitable transactions made by Daniel Elger is 0%.
What is the average return per transaction made by Daniel Elger?
The average return per transaction made by Daniel Elger is -15.40%.
What stocks does Daniel Elger hold?
Daniel Elger holds: GB:ETX stocks.
What was Daniel Elger’s latest transaction?
Daniel Elger’s latest transaction was an Informative Buy of 4.80K .
What is Daniel Elger's role in E Therapeutics?
Daniel Elger's role in E Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
